Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib vs Naproxen in Acute Musculoskeletal Pain
NCT00170898Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lumiracoxib in acute musculoskeletal pain (2 arms), sponsored by Novartis. Primary endpoint: Sum of Pain Intensity Difference over first 5 days. Started Nov 2004; status: completed.
02
Drugs
lumiracoxib
03
Conditions
acute musculoskeletal pain
Beyond the preview
Go deeper on NCT00170898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170898.